European Association of Pharma Biotechnology - EAPB
Europäische Arbeitsgemeinschaft für Pharma Biotechnologie
Association Européenne de Pharma Biotechnologie

EAPB is the representative and central network to promote and develop Pharma Biotechnology in Europe, linking academia, industries and regulatory bodies.

Members are scientists (individual membership), companies, departments of companies and organisations from academia (corporate membership), but also industry, especially pharmaceutical industry and related sciences involved in pharma biotechnology.

Primary aim of the EAPB is the promotion of pharma biotechnology as an independant multidisciplinary science in all European countries, especially promoting the co-operation and scientific exchange between the various disciplines contributing to pharma biotechnology.

Establishment and further promotion of pharma biotechnology as a multidisciplinary part in pharmaceutical sciences (pharmacy).

The EAPB will promote the introduction of pharma biotechnology in the curricula of pharmacists and other persons in the pharmaceutical area. Special consideration will be given to industrial needs to ensure the future of pharma biotechnology and an optimal educational profile of the occupational groups in this area. Criteria for the educational training and curriculi of pharmacy students, PhD students and technicians will be put together and presented on the political platform.

.

The EAPB is a forum for exchange of experiences and knowledge and for the promotion of the multidisciplinary co-operation including science transfer in the area of pharma biotechnology (e.g. conferences, workshops in co-operation with existing scientific societies).

.

The EAPB will contribute towards the co-ordination and harmonisation of pharma biotechnological activities in Europe.

.

The EAPB proposes and promotes the establishment of a pharma biotechnological network in Europe, especially within the framework of European programs.

.

Expert meetings for further promotion of the science pharma biotechnology
.

Establishment of special task forces for special aims
.

Co-ordination of activities in the area of pharma biotechnology in co-operation with other organisations, e. g. APV, APGI, EUFEPS, FIP etc.
.

Expert meetings within biotechnology conferences

.

An optimised organisation form will be chosen (e. g. charity society, membership contributions deductible from tax).

The first board of governors will be elected during the foundation meeting on 2 April 2000 in Berlin. The board of governors should be international and consist of members from academia but also from industry (e. g. 3 members of presidential board (1 president, 2 vice presidents), 1 secretary, 1 treasurer, and 3-6 board members).